Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 5/2008

01-05-2008 | Research Letter

Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland

Authors: N. Lammi, P. A. Blomstedt, E. Moltchanova, J. G. Eriksson, J. Tuomilehto, M. Karvonen

Published in: Diabetologia | Issue 5/2008

Login to get access

Excerpt

To the Editor: Previously we reported data on trends in the incidence of type 1 and type 2 diabetes in Finnish young adults aged 15–39 years during 1992–1996 [1] and found a 7.9% average annual increase in the incidence of type 2 diabetes. This rising trend needed to be confirmed during a longer period of follow-up, and therefore we extended the study until the year 2001. …
Literature
1.
Lammi N, Taskinen O, Moltchanova E et al (2007) A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland during 1992 to 1996. Diabetologia 50:1393–1400PubMedCrossRef
2.
3.
4.
American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43–S48
5.
6.
7.
The DiaMond Study Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef
8.
Mattsson N, Ronnemaa T, Juonala M, Viikari JS, Raitakari OT (2007) The prevalence of the metabolic syndrome in young adults. The cardiovascular risk in young Finns study. J Intern Med 261:159–169PubMedCrossRef
Metadata
Title
Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland
Authors
N. Lammi
P. A. Blomstedt
E. Moltchanova
J. G. Eriksson
J. Tuomilehto
M. Karvonen
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0952-9

Other articles of this Issue 5/2008

Diabetologia 5/2008 Go to the issue

Review

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

Article

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action

Article

Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial

Editorial

Who needs the diabetes specialist physician?

Letter

Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment

Letter

Caveats regarding the use of HbA1c for prediction of mean blood glucose
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits